APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Ingredient Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Ingredient Testing Service Market Analysis and Forecast 2026-2032

1 January 2026208 pages

Choose your research edition.

Industry ResearchDrug Ingredient Testing Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Ingredient Testing Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Drug Ingredient Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Ingredient Testing Service Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Ingredient Testing Service Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Drug Ingredient Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Ingredient Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Ingredient Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Ingredient Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Ingredient Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Ingredient Testing Service include Eurofins Scientific, Nelson Labs, Creative Proteomics, SGS S.A., CPT Labs, ADPEN Laboratories, Cotecn, Curia Global and Evans Analytical Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Ingredient Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Ingredient Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Ingredient Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Ingredient Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Ingredient Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Ingredient Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Drug Ingredient Testing Service Segment by Company

Eurofins Scientific

Nelson Labs

Creative Proteomics

SGS S.A.

CPT Labs

ADPEN Laboratories

Cotecn

Curia Global

Evans Analytical Group

Vetter Pharma

Almac

Q Laboratories

Contract Laboratory

Consumer Product Testing Company

Tentamus Group

Auriga Research

Drug Ingredient Testing Service Segment by Type

Veterinary Drug Testing

Drug Testing

Pesticide Testing

Drug Ingredient Testing Service Segment by Application

Drug Research and Development

Quality Control

Clinical Research

Drug Supervision

Others

Drug Ingredient Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Ingredient Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Ingredient Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Ingredient Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Ingredient Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Ingredient Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Ingredient Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Ingredient Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Veterinary Drug Testing Major Player Table 3. Drug Testing Major Player Table 4. Pesticide Testing Major Player Table 5. Global Drug Ingredient Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Research and Development Major Player Table 7. Quality Control Major Player Table 8. Clinical Research Major Player Table 9. Drug Supervision Major Player Table 10. Others Major Player Table 11. Drug Ingredient Testing Service Industry Trends Table 12. Drug Ingredient Testing Service Industry Drivers Table 13. Drug Ingredient Testing Service Industry Opportunities and Challenges Table 14. Drug Ingredient Testing Service Industry Restraints Table 15. Global Drug Ingredient Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Drug Ingredient Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Drug Ingredient Testing Service Market Share by Region (2021-2026) Table 18. Global Drug Ingredient Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Drug Ingredient Testing Service Market Share by Region (2027-2032) Table 20. Global Drug Ingredient Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Drug Ingredient Testing Service Revenue Market Share by Players (2021-2026) Table 22. Global Drug Ingredient Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Drug Ingredient Testing Service Key Players Headquarters & Area Served Table 24. Global Drug Ingredient Testing Service Players, Product Type & Application Table 25. Global Drug Ingredient Testing Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Drug Ingredient Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Drug Ingredient Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Drug Ingredient Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Drug Ingredient Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Drug Ingredient Testing Service Revenue Market Share by Type (2021-2026) Table 32. Global Drug Ingredient Testing Service Revenue Market Share by Type (2027-2032) Table 33. Global Drug Ingredient Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Drug Ingredient Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Drug Ingredient Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Drug Ingredient Testing Service Revenue Market Share by Application (2021-2026) Table 37. Global Drug Ingredient Testing Service Revenue Market Share by Application (2027-2032) Table 38. Eurofins Scientific Company Information Table 39. Eurofins Scientific Business Overview Table 40. Eurofins Scientific Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Eurofins Scientific Drug Ingredient Testing Service Product Portfolio Table 42. Eurofins Scientific Recent Development Table 43. Nelson Labs Company Information Table 44. Nelson Labs Business Overview Table 45. Nelson Labs Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Nelson Labs Drug Ingredient Testing Service Product Portfolio Table 47. Nelson Labs Recent Development Table 48. Creative Proteomics Company Information Table 49. Creative Proteomics Business Overview Table 50. Creative Proteomics Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Creative Proteomics Drug Ingredient Testing Service Product Portfolio Table 52. Creative Proteomics Recent Development Table 53. SGS S.A. Company Information Table 54. SGS S.A. Business Overview Table 55. SGS S.A. Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. SGS S.A. Drug Ingredient Testing Service Product Portfolio Table 57. SGS S.A. Recent Development Table 58. CPT Labs Company Information Table 59. CPT Labs Business Overview Table 60. CPT Labs Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. CPT Labs Drug Ingredient Testing Service Product Portfolio Table 62. CPT Labs Recent Development Table 63. ADPEN Laboratories Company Information Table 64. ADPEN Laboratories Business Overview Table 65. ADPEN Laboratories Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. ADPEN Laboratories Drug Ingredient Testing Service Product Portfolio Table 67. ADPEN Laboratories Recent Development Table 68. Cotecn Company Information Table 69. Cotecn Business Overview Table 70. Cotecn Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Cotecn Drug Ingredient Testing Service Product Portfolio Table 72. Cotecn Recent Development Table 73. Curia Global Company Information Table 74. Curia Global Business Overview Table 75. Curia Global Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Curia Global Drug Ingredient Testing Service Product Portfolio Table 77. Curia Global Recent Development Table 78. Evans Analytical Group Company Information Table 79. Evans Analytical Group Business Overview Table 80. Evans Analytical Group Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Evans Analytical Group Drug Ingredient Testing Service Product Portfolio Table 82. Evans Analytical Group Recent Development Table 83. Vetter Pharma Company Information Table 84. Vetter Pharma Business Overview Table 85. Vetter Pharma Drug Ingredient Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Vetter Pharma Drug Ingredient Testing Service Product Portfolio Table 87. Vetter Pharma Recent Development Table 88. Almac Company Information Table 89. Almac Business Overview Table 90. Almac Drug Ingredient Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Almac Drug Ingredient Testing Service Product Portfolio Table 92. Almac Recent Development Table 93. Q Laboratories Company Information Table 94. Q Laboratories Business Overview Table 95. Q Laboratories Drug Ingredient Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Q Laboratories Drug Ingredient Testing Service Product Portfolio Table 97. Q Laboratories Recent Development Table 98. Contract Laboratory Company Information Table 99. Contract Laboratory Business Overview Table 100. Contract Laboratory Drug Ingredient Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Contract Laboratory Drug Ingredient Testing Service Product Portfolio Table 102. Contract Laboratory Recent Development Table 103. Consumer Product Testing Company Company Information Table 104. Consumer Product Testing Company Business Overview Table 105. Consumer Product Testing Company Drug Ingredient Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Consumer Product Testing Company Drug Ingredient Testing Service Product Portfolio Table 107. Consumer Product Testing Company Recent Development Table 108. Tentamus Group Company Information Table 109. Tentamus Group Business Overview Table 110. Tentamus Group Drug Ingredient Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Tentamus Group Drug Ingredient Testing Service Product Portfolio Table 112. Tentamus Group Recent Development Table 113. Auriga Research Company Information Table 114. Auriga Research Business Overview Table 115. Auriga Research Drug Ingredient Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Auriga Research Drug Ingredient Testing Service Product Portfolio Table 117. Auriga Research Recent Development Table 118. North America Drug Ingredient Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Drug Ingredient Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Drug Ingredient Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Drug Ingredient Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Drug Ingredient Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. North America Drug Ingredient Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 124. North America Drug Ingredient Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 125. Europe Drug Ingredient Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Drug Ingredient Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Drug Ingredient Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Drug Ingredient Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Drug Ingredient Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Drug Ingredient Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Drug Ingredient Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 132. China Drug Ingredient Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 133. China Drug Ingredient Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 134. China Drug Ingredient Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 135. China Drug Ingredient Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Drug Ingredient Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Drug Ingredient Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Drug Ingredient Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Drug Ingredient Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Drug Ingredient Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Drug Ingredient Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 142. Asia Drug Ingredient Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 143. SAMEA Drug Ingredient Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 144. SAMEA Drug Ingredient Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 145. SAMEA Drug Ingredient Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 146. SAMEA Drug Ingredient Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 147. SAMEA Drug Ingredient Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. SAMEA Drug Ingredient Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 149. SAMEA Drug Ingredient Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Drug Ingredient Testing Service Image Figure 2. Global Drug Ingredient Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Ingredient Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Veterinary Drug Testing Image Figure 5. Drug Testing Image Figure 6. Pesticide Testing Image Figure 7. Global Drug Ingredient Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug Ingredient Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Research and Development Image Figure 10. Quality Control Image Figure 11. Clinical Research Image Figure 12. Drug Supervision Image Figure 13. Others Image Figure 14. Global Drug Ingredient Testing Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Drug Ingredient Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Drug Ingredient Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Drug Ingredient Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Drug Ingredient Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drug Ingredient Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Drug Ingredient Testing Service Revenue Market Share by Type (2021-2032) Figure 22. Global Drug Ingredient Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drug Ingredient Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Drug Ingredient Testing Service Revenue Market Share by Application (2021-2032) Figure 25. North America Drug Ingredient Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Drug Ingredient Testing Service Revenue Share by Type (2021-2032) Figure 27. North America Drug Ingredient Testing Service Revenue Share by Application (2021-2032) Figure 28. North America Drug Ingredient Testing Service Revenue Share by Country (2021-2032) Figure 29. United States Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Drug Ingredient Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Drug Ingredient Testing Service Revenue Share by Type (2021-2032) Figure 34. Europe Drug Ingredient Testing Service Revenue Share by Application (2021-2032) Figure 35. Europe Drug Ingredient Testing Service Revenue Share by Country (2021-2032) Figure 36. Germany Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Drug Ingredient Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Drug Ingredient Testing Service Revenue Share by Type (2021-2032) Figure 46. China Drug Ingredient Testing Service Revenue Share by Application (2021-2032) Figure 47. Asia Drug Ingredient Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Drug Ingredient Testing Service Revenue Share by Type (2021-2032) Figure 49. Asia Drug Ingredient Testing Service Revenue Share by Application (2021-2032) Figure 50. Asia Drug Ingredient Testing Service Revenue Share by Region (2021-2032) Figure 51. Japan Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Drug Ingredient Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Drug Ingredient Testing Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Drug Ingredient Testing Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Drug Ingredient Testing Service Revenue Share by Country (2021-2032) Figure 61. Brazil Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Drug Ingredient Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Veterinary Drug Testing
  • Drug Testing
  • Pesticide Testing
Applications
  • Drug Research and Development
  • Quality Control
  • Clinical Research
  • Drug Supervision
  • Others
Companies covered
  • Eurofins Scientific
  • Nelson Labs
  • Creative Proteomics
  • SGS S.A.
  • CPT Labs
  • ADPEN Laboratories
  • Cotecn
  • Curia Global
  • Evans Analytical Group
  • Vetter Pharma
  • Almac
  • Q Laboratories
  • Contract Laboratory
  • Consumer Product Testing Company
  • Tentamus Group
  • Auriga Research

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Ingredient Testing Service Market by Type
  3. 1.2.1 Global Drug Ingredient Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Veterinary Drug Testing
  5. 1.2.3 Drug Testing
  6. 1.2.4 Pesticide Testing
  7. 1.3 Drug Ingredient Testing Service Market by Application
  8. 1.3.1 Global Drug Ingredient Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Research and Development
  10. 1.3.3 Quality Control
  11. 1.3.4 Clinical Research
  12. 1.3.5 Drug Supervision
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Drug Ingredient Testing Service Market Dynamics
  1. 2.1 Drug Ingredient Testing Service Industry Trends
  2. 2.2 Drug Ingredient Testing Service Industry Drivers
  3. 2.3 Drug Ingredient Testing Service Industry Opportunities and Challenges
  4. 2.4 Drug Ingredient Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Ingredient Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Drug Ingredient Testing Service Growth Trends by Region
  3. 3.2.1 Global Drug Ingredient Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Ingredient Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Ingredient Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Ingredient Testing Service Revenue by Players
  2. 4.1.1 Global Drug Ingredient Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Ingredient Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Ingredient Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Ingredient Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Ingredient Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Drug Ingredient Testing Service Players, Product Type & Application
  8. 4.5 Global Drug Ingredient Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Ingredient Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Drug Ingredient Testing Service Tier 1, Tier 2, and Tier 3
5 Drug Ingredient Testing Service Market Size by Type
  1. 5.1 Global Drug Ingredient Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Ingredient Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Drug Ingredient Testing Service Revenue Market Share by Type (2021-2032)
6 Drug Ingredient Testing Service Market Size by Application
  1. 6.1 Global Drug Ingredient Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Ingredient Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Drug Ingredient Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Scientific
  2. 7.1.1 Eurofins Scientific Company Information
  3. 7.1.2 Eurofins Scientific Business Overview
  4. 7.1.3 Eurofins Scientific Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Scientific Drug Ingredient Testing Service Product Portfolio
  6. 7.1.5 Eurofins Scientific Recent Developments
  7. 7.2 Nelson Labs
  8. 7.2.1 Nelson Labs Company Information
  9. 7.2.2 Nelson Labs Business Overview
  10. 7.2.3 Nelson Labs Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Nelson Labs Drug Ingredient Testing Service Product Portfolio
  12. 7.2.5 Nelson Labs Recent Developments
  13. 7.3 Creative Proteomics
  14. 7.3.1 Creative Proteomics Company Information
  15. 7.3.2 Creative Proteomics Business Overview
  16. 7.3.3 Creative Proteomics Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative Proteomics Drug Ingredient Testing Service Product Portfolio
  18. 7.3.5 Creative Proteomics Recent Developments
  19. 7.4 SGS S.A.
  20. 7.4.1 SGS S.A. Company Information
  21. 7.4.2 SGS S.A. Business Overview
  22. 7.4.3 SGS S.A. Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SGS S.A. Drug Ingredient Testing Service Product Portfolio
  24. 7.4.5 SGS S.A. Recent Developments
  25. 7.5 CPT Labs
  26. 7.5.1 CPT Labs Company Information
  27. 7.5.2 CPT Labs Business Overview
  28. 7.5.3 CPT Labs Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CPT Labs Drug Ingredient Testing Service Product Portfolio
  30. 7.5.5 CPT Labs Recent Developments
  31. 7.6 ADPEN Laboratories
  32. 7.6.1 ADPEN Laboratories Company Information
  33. 7.6.2 ADPEN Laboratories Business Overview
  34. 7.6.3 ADPEN Laboratories Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ADPEN Laboratories Drug Ingredient Testing Service Product Portfolio
  36. 7.6.5 ADPEN Laboratories Recent Developments
  37. 7.7 Cotecn
  38. 7.7.1 Cotecn Company Information
  39. 7.7.2 Cotecn Business Overview
  40. 7.7.3 Cotecn Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cotecn Drug Ingredient Testing Service Product Portfolio
  42. 7.7.5 Cotecn Recent Developments
  43. 7.8 Curia Global
  44. 7.8.1 Curia Global Company Information
  45. 7.8.2 Curia Global Business Overview
  46. 7.8.3 Curia Global Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Curia Global Drug Ingredient Testing Service Product Portfolio
  48. 7.8.5 Curia Global Recent Developments
  49. 7.9 Evans Analytical Group
  50. 7.9.1 Evans Analytical Group Company Information
  51. 7.9.2 Evans Analytical Group Business Overview
  52. 7.9.3 Evans Analytical Group Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Evans Analytical Group Drug Ingredient Testing Service Product Portfolio
  54. 7.9.5 Evans Analytical Group Recent Developments
  55. 7.10 Vetter Pharma
  56. 7.10.1 Vetter Pharma Company Information
  57. 7.10.2 Vetter Pharma Business Overview
  58. 7.10.3 Vetter Pharma Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Vetter Pharma Drug Ingredient Testing Service Product Portfolio
  60. 7.10.5 Vetter Pharma Recent Developments
  61. 7.11 Almac
  62. 7.11.1 Almac Company Information
  63. 7.11.2 Almac Business Overview
  64. 7.11.3 Almac Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Almac Drug Ingredient Testing Service Product Portfolio
  66. 7.11.5 Almac Recent Developments
  67. 7.12 Q Laboratories
  68. 7.12.1 Q Laboratories Company Information
  69. 7.12.2 Q Laboratories Business Overview
  70. 7.12.3 Q Laboratories Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Q Laboratories Drug Ingredient Testing Service Product Portfolio
  72. 7.12.5 Q Laboratories Recent Developments
  73. 7.13 Contract Laboratory
  74. 7.13.1 Contract Laboratory Company Information
  75. 7.13.2 Contract Laboratory Business Overview
  76. 7.13.3 Contract Laboratory Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Contract Laboratory Drug Ingredient Testing Service Product Portfolio
  78. 7.13.5 Contract Laboratory Recent Developments
  79. 7.14 Consumer Product Testing Company
  80. 7.14.1 Consumer Product Testing Company Company Information
  81. 7.14.2 Consumer Product Testing Company Business Overview
  82. 7.14.3 Consumer Product Testing Company Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Consumer Product Testing Company Drug Ingredient Testing Service Product Portfolio
  84. 7.14.5 Consumer Product Testing Company Recent Developments
  85. 7.15 Tentamus Group
  86. 7.15.1 Tentamus Group Company Information
  87. 7.15.2 Tentamus Group Business Overview
  88. 7.15.3 Tentamus Group Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Tentamus Group Drug Ingredient Testing Service Product Portfolio
  90. 7.15.5 Tentamus Group Recent Developments
  91. 7.16 Auriga Research
  92. 7.16.1 Auriga Research Company Information
  93. 7.16.2 Auriga Research Business Overview
  94. 7.16.3 Auriga Research Drug Ingredient Testing Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Auriga Research Drug Ingredient Testing Service Product Portfolio
  96. 7.16.5 Auriga Research Recent Developments
8 North America
  1. 8.1 North America Drug Ingredient Testing Service Revenue (2021-2032)
  2. 8.2 North America Drug Ingredient Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Ingredient Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Ingredient Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Drug Ingredient Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Ingredient Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Ingredient Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Ingredient Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Drug Ingredient Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Ingredient Testing Service Revenue by Country
  11. 8.6.1 North America Drug Ingredient Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Ingredient Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Ingredient Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Ingredient Testing Service Revenue (2021-2032)
  2. 9.2 Europe Drug Ingredient Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Ingredient Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Ingredient Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Ingredient Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Ingredient Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Ingredient Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Ingredient Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Ingredient Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Ingredient Testing Service Revenue by Country
  11. 9.6.1 Europe Drug Ingredient Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Ingredient Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Ingredient Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Ingredient Testing Service Revenue (2021-2032)
  2. 10.2 China Drug Ingredient Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Ingredient Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Ingredient Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Drug Ingredient Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Ingredient Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Ingredient Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Ingredient Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Drug Ingredient Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Ingredient Testing Service Revenue (2021-2032)
  2. 11.2 Asia Drug Ingredient Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Ingredient Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Ingredient Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Ingredient Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Ingredient Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Ingredient Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Ingredient Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Ingredient Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Ingredient Testing Service Revenue by Country
  11. 11.6.1 Asia Drug Ingredient Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Ingredient Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Ingredient Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Ingredient Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Drug Ingredient Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Ingredient Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Ingredient Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Ingredient Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Ingredient Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Ingredient Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Ingredient Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Ingredient Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Ingredient Testing Service Revenue by Country
  11. 12.6.1 SAMEA Drug Ingredient Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Ingredient Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Ingredient Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst